Education
About Us
Working with TipRanks
Follow Us
Eterna Therapeutics (ERNA)
NASDAQ:ERNA
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 582.00K | $ 68.00K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 486.00K | $ -168.00K | $ -497.00K | $ -459.00K | $ -98.00K |
| Operating Income | $ -15.67M | $ -21.14M | $ -33.22M | $ 68.34M | $ -7.25M |
| EBITDA | $ -15.67M | $ -19.93M | $ -33.22M | $ -121.95M | $ -7.15M |
| Net Income | $ -44.55M | $ -21.67M | $ -24.58M | $ -122.31M | $ 11.91M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.73M | $ 7.58M | $ 11.45M | $ 16.98M | $ 1.63M |
| Total Assets | $ 5.27M | $ 49.13M | $ 22.28M | $ 32.43M | $ 12.91M |
| Total Debt | $ 684.00K | $ 41.84M | $ 4.14M | $ 2.72M | $ 2.90M |
| Net Debt | $ -1.04M | $ 34.27M | $ -7.31M | $ -14.26M | $ 1.27M |
| Total Liabilities | $ 3.57M | $ 46.90M | $ 10.17M | $ 25.93M | $ 5.25M |
| Stockholders' Equity | $ 1.70M | $ 2.23M | $ 12.11M | $ 6.50M | $ 7.66M |
| Cash Flow | |||||
| Free Cash Flow | $ -16.20M | $ -20.43M | $ -21.27M | $ -23.64M | $ -8.14M |
| Operating Cash Flow | $ -15.84M | $ -20.41M | $ -20.98M | $ -23.49M | $ -8.10M |
| Investing Cash Flow | $ -365.00K | $ -19.00K | $ -47.00K | $ -22.74M | $ -39.00K |
| Financing Cash Flow | $ 6.26M | $ 16.56M | $ 19.58M | $ 61.59M | $ 4.67M |